Age, Biography and Wiki
Katalin Kariko is a Hungarian biochemist and professor at the University of Pennsylvania. She is best known for her pioneering work in the field of RNA interference (RNAi). She has made significant contributions to the understanding of the mechanism of action of small interfering RNAs (siRNAs) and their therapeutic potential. Katalin Kariko was born on 17 January 1955 in Szolnok, Hungary. She received her PhD in biochemistry from the University of Szeged in Hungary in 1982. She then moved to the United States and completed postdoctoral studies at the University of California, San Francisco. Katalin Kariko has made significant contributions to the understanding of the mechanism of action of small interfering RNAs (siRNAs) and their therapeutic potential. She has published over 100 scientific papers and holds several patents related to her research. She is a member of the National Academy of Sciences and the American Academy of Arts and Sciences. Katalin Kariko has an estimated net worth of $1 million. She has earned her wealth through her successful career as a biochemist and professor.
| Popular As | N/A |
| Occupation | N/A |
| Age | 68 years old |
| Zodiac Sign | Capricorn |
| Born | 17 January, 1955 |
| Birthday | 17 January |
| Birthplace | Szolnok, Hungary |
| Nationality | Hungary |
We recommend you to check the complete list of Famous People born on 17 January. She is a member of famous with the age 68 years old group.
Katalin Kariko Height, Weight & Measurements
At 68 years old, Katalin Kariko height not available right now. We will update Katalin Kariko's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status | |
|---|---|
| Height | Not Available |
| Weight | Not Available |
| Body Measurements | Not Available |
| Eye Color | Not Available |
| Hair Color | Not Available |
Who Is Katalin Kariko's Husband?
Her husband is Béla Francia
| Family | |
|---|---|
| Parents | Not Available |
| Husband | Béla Francia |
| Sibling | Not Available |
| Children | Susan Francia |
Katalin Kariko Net Worth
Her net worth has been growing significantly in 2022-2023. So, how much is Katalin Kariko worth at the age of 68 years old? Katalin Kariko’s income source is mostly from being a successful . She is from Hungary. We have estimated Katalin Kariko's net worth , money, salary, income, and assets.
| Net Worth in 2023 | $1 Million - $5 Million |
| Salary in 2023 | Under Review |
| Net Worth in 2022 | Pending |
| Salary in 2022 | Under Review |
| House | Not Available |
| Cars | Not Available |
| Source of Income |
Katalin Kariko Social Network
Timeline
The work and research of Karikó has contributed to BioNTech’s effort to create immune cells that produce vaccine antigens — Karikó’s research revealed the ability to leverage the antiviral response to mRNA to give their cancer vaccines an extra boost in defense against tumors.
In 2012, Karikó and Drew Weissman, an immunologist at the University of Pennsylvania, received a patent for the use of several modified nucleosides to reduce the antiviral immune response to mRNA and they founded a small company. Soon after, UPenn sold the intellectual property license to Gary Dahl, the head of a lab supply company that eventually became Cellscript. Weeks later, Flagship Pioneering, the venture capital company who was and still is backing Moderna, contacted her in hopes of licensing the patent. All Karikó said was “we don’t have it.” In early 2013, Karikó heard of Moderna’s $240 million deal with AstraZeneca to develop a VEGF mRNA. Karikó realized she would not get a chance to apply her experience with mRNA at UPenn and took her role as Senior Vice President at BioNTech RNA Pharmaceuticals.
Karikó's work includes scientific research of RNA-mediated immune activation resulting in the co-discovery of the nucleoside modifications that suppress the immunogenicity of RNA. This is seen as expanding the therapeutic potential of mRNA. She holds patents granted in the United States for application of non-immunogenic, nucleoside-modified RNA. She co-founded and served as CEO of RNARx from 2006-2013.. Katalin Karikó is the mother of 2-time Olympic Gold Medalist Susan Francia.
In 1990, while a Professor at the University of Pennsylvania, Karikó submitted her first grant application in which she proposed to establish mRNA-based gene therapy, Ever since, mRNA-based therapy has been Karikó’s primary research interest. Karikó served for nearly 25 years as a Professor at the University of Pennsylvania Medical School.
Katalin Karikó (born 17 January 1955 in Szolnok, Hungary) is a Hungarian biochemist who specializes in RNA-mediated mechanisms. Her research has been the development of vitro-transcribed mRNA for protein therapies. She currently serves as the Senior Vice President at BioNTech RNA Pharmaceuticals.
